ICCM
IceCure Medical LtdNASDAQHealthcare$0.30+0.57%ClosedMarket Cap: $20.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.43
P/S
6.13
EV/EBITDA
-0.81
DCF Value
$-0.22
FCF Yield
-72.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
36.3%
Operating Margin
-863.5%
Net Margin
-445.6%
ROE
-221.0%
ROA
-108.4%
ROIC
-314.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.3M | 46.9% | $-4.2M | $-4.2M | $-0.06 | — |
| FY 2025 | $3.4M | 32.8% | $-15.1M | $-15.1M | $-0.24 | — |
| Q3 2025 | $850.0K | 32.6% | $-17.9M | $-3.9M | $-0.06 | — |
| Q2 2025 | $525.0K | 25.0% | $-3.4M | $-3.4M | $-0.06 | — |
| Q1 2025 | $725.0K | 30.1% | $-3.7M | $-3.6M | $-0.06 | — |
| Q4 2024 | $875.0K | 47.7% | $-4.5M | $-4.5M | $-0.08 | — |
| FY 2024 | $3.3M | 44.1% | $-15.7M | $-15.3M | $-0.30 | — |
| Q3 2024 | $662.0K | 35.5% | $-4.3M | $-4.1M | $-0.08 | — |
| Q2 2024 | $1.0M | 52.4% | $-3.2M | $-3.1M | $-0.06 | — |
| Q1 2024 | $736.4K | 36.2% | $-3.6M | $-3.6M | $-0.08 | — |
| Q4 2023 | $1.3M | 45.3% | $-3.6M | $-3.2M | $-0.07 | — |
| FY 2023 | $3.2M | 40.3% | $-15.6M | $-14.7M | $-0.32 | — |